We have located links that may give you full text access.
Preparation and in vitro evaluation of FGF-2 incorporated carboxymethyl chitosan nanoparticles.
Carbohydrate Polymers 2017 October 2
Fibroblast growth factor 2 (FGF-2) is a multi-functional protein involving in wound healing. However, FGF-2 is easily degradable in vivo, which limited its use for wound treatment. In this study, we investigated a drug-delivery model for FGF-2 via incorporation with biodegradable carboxylmethyl chitosan (CMCS). CMCS nanoparticles (NPs) could be synthesized by ionic gelation using CaCl2 as a crosslinking reagent with the CMCS:CaCl2 ratio of 1:0.8. Synthesized CMCS NPs had a diameter of 32.68±6.83nm, and were non-toxic at concentrations up to 2.5mg/ml. Incorporated CMCS:FGF-2 NPs had a diameter of 34.83±5.89nm and incorporation efficiency was 95%. CMCS:FGF-2 NPs released 36.36% and 58.47% of FGF-2 after 48h incubation in two different pH of 7.4 and 5.8, respectively. The incorporation and release processes did not have a significant effect on FGF-2 activity. Simultaneously, CMCS:FGF-2 NPs could protect FGF-2 from the degradation of trypsin in vitro. Our results laid the groundwork for the manufacturing of protein incorporated CMCS NPs for bio-applications.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app